{
    "clinical_study": {
        "@rank": "99390", 
        "brief_summary": {
            "textblock": "This Phase I study will assess the pharmacokinetics of two botanicals, Trifolium pratense\n      (red clover) and Cimicifuga racemosa (black cohosh).  Participants will receive a single\n      dose of one botanical preparation. The observation period will be one week. Drug toxicity,\n      absorption, distribution, metabolism and elimination data will be collected, and dosages to\n      be utilized in a Phase II clinical trial will be determined."
        }, 
        "brief_title": "Single-Dose Study of Black Cohosh and Red Clover", 
        "completion_date": "February 2002", 
        "condition": "Menopause", 
        "detailed_description": {
            "textblock": "This Phase I study will assess the pharmacokinetics of two botanicals, Trifolium pratense\n      (red clover) and Cimicifuga racemosa (black cohosh).  Participants will receive a single\n      dose of one botanical preparation. The observation period will be one week. Drug toxicity,\n      absorption, distribution, metabolism and elimination data will be collected, and dosages to\n      be utilized in a Phase II clinical trial will be determined. The Phase II trial will examine\n      the efficacies of red clover and black cohosh for the reduction of menopausal symptoms in\n      healthy menopausal women.  The  study will be randomized, double-blinded, and\n      placebo-controlled.  Study duration will be one year."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Healthy menopausal women\n\n          -  Average body weight\n\n          -  Able to give informed consent\n\n        Exclusion Criteria:\n\n          -  Smoker\n\n          -  Use of any prescription medicine within the last 2 months\n\n          -  Obesity > 30% above ideal body weight\n\n          -  Previous history of breast or reproductive cancer\n\n          -  Alcohol abuse or consumption above 5 glasses of wine per week or equivalent\n\n          -  Chronic disease such as diabetes or hypertension\n\n          -  Concurrent non-dietary phytoestrogens or hormone use; Vegans (vegetarians who tend to\n             consume greater than average dose of phytoestrogens)\n\n          -  Concurrent participation in other clinical trial(s)\n\n          -  Unavailable for followup"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "59 Years", 
            "minimum_age": "45 Years"
        }, 
        "enrollment": "30", 
        "firstreceived_date": "February 2, 2001", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_alias": "NCT00008970", 
            "nct_id": "NCT00010959", 
            "org_study_id": "P50 AT000155-01P4", 
            "secondary_id": "P50 AT000155-01"
        }, 
        "intervention": [
            {
                "intervention_name": "Cimicifuga racemosa", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "Trifolium pratense", 
                "intervention_type": "Drug"
            }
        ], 
        "keyword": [
            "menopause", 
            "hot flashes", 
            "botanicals"
        ], 
        "lastchanged_date": "March 1, 2007", 
        "link": {
            "description": "Click here for information on the UIC/NIH Center for Botanical Dietary Supplements Research", 
            "url": "http://www.uic.edu/pharmacy/research/diet/"
        }, 
        "official_title": "A Phase I Single-Dose Pharmacokinetic Study of Black Cohosh and Red Clover in Healthy Menopausal Women 45-59 Years of Age", 
        "overall_official": {
            "affiliation": "University of Illinois at Chicago", 
            "last_name": "Suzanne Banuvar, MHSA, CCRC", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_outcome": {
            "measure": "safety"
        }, 
        "removed_countries": {
            "country": "United States"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00010959"
        }, 
        "source": "National Center for Complementary and Alternative Medicine (NCCAM)", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "National Institute of General Medical Sciences (NIGMS)", 
                    "agency_class": "NIH"
                }, 
                {
                    "agency": "Office of Dietary Supplements (ODS)", 
                    "agency_class": "NIH"
                }
            ], 
            "lead_sponsor": {
                "agency": "National Center for Complementary and Alternative Medicine (NCCAM)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "February 2001", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2007"
    }, 
    "geocoordinates": {}
}